nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C19—epilepsy syndrome	0.132	0.44	CbGaD
Loratadine—CYP2D6—epilepsy syndrome	0.0982	0.327	CbGaD
Loratadine—ABCB1—epilepsy syndrome	0.0701	0.233	CbGaD
Loratadine—CYP2C8—Trimethadione—epilepsy syndrome	0.018	0.0368	CbGbCtD
Loratadine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0169	0.0346	CbGbCtD
Loratadine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0162	0.0332	CbGbCtD
Loratadine—CYP2C19—Trimethadione—epilepsy syndrome	0.0151	0.0309	CbGbCtD
Loratadine—CYP2C19—Felbamate—epilepsy syndrome	0.0151	0.0309	CbGbCtD
Loratadine—ABCB1—Levetiracetam—epilepsy syndrome	0.0143	0.0293	CbGbCtD
Loratadine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0142	0.029	CbGbCtD
Loratadine—CYP2C9—Trimethadione—epilepsy syndrome	0.0125	0.0257	CbGbCtD
Loratadine—CYP2C19—Clobazam—epilepsy syndrome	0.0123	0.0252	CbGbCtD
Loratadine—CYP2C8—Carbamazepine—epilepsy syndrome	0.0122	0.0248	CbGbCtD
Loratadine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0118	0.0241	CbGbCtD
Loratadine—CYP2C8—Primidone—epilepsy syndrome	0.0113	0.0232	CbGbCtD
Loratadine—CYP2C8—Phenytoin—epilepsy syndrome	0.0109	0.0223	CbGbCtD
Loratadine—CYP2C19—Carbamazepine—epilepsy syndrome	0.0102	0.0208	CbGbCtD
Loratadine—CYP2C8—Propofol—epilepsy syndrome	0.0102	0.0208	CbGbCtD
Loratadine—ABCB1—Clobazam—epilepsy syndrome	0.00993	0.0203	CbGbCtD
Loratadine—CYP2C8—Phenobarbital—epilepsy syndrome	0.00971	0.0199	CbGbCtD
Loratadine—ABCB1—Lamotrigine—epilepsy syndrome	0.00956	0.0195	CbGbCtD
Loratadine—CYP2C19—Primidone—epilepsy syndrome	0.00952	0.0195	CbGbCtD
Loratadine—CYP2C8—Diazepam—epilepsy syndrome	0.00921	0.0188	CbGbCtD
Loratadine—CYP2C19—Phenytoin—epilepsy syndrome	0.00914	0.0187	CbGbCtD
Loratadine—CYP2C19—Propofol—epilepsy syndrome	0.00853	0.0174	CbGbCtD
Loratadine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00848	0.0173	CbGbCtD
Loratadine—ABCB1—Carbamazepine—epilepsy syndrome	0.00823	0.0168	CbGbCtD
Loratadine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00815	0.0167	CbGbCtD
Loratadine—CYP2C9—Primidone—epilepsy syndrome	0.00791	0.0162	CbGbCtD
Loratadine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00785	0.016	CbGbCtD
Loratadine—CYP2C19—Diazepam—epilepsy syndrome	0.00773	0.0158	CbGbCtD
Loratadine—CYP2C9—Phenytoin—epilepsy syndrome	0.0076	0.0155	CbGbCtD
Loratadine—CYP2C19—Zonisamide—epilepsy syndrome	0.00754	0.0154	CbGbCtD
Loratadine—ABCB1—Phenytoin—epilepsy syndrome	0.00738	0.0151	CbGbCtD
Loratadine—CYP3A4—Felbamate—epilepsy syndrome	0.0073	0.0149	CbGbCtD
Loratadine—CYP3A4—Trimethadione—epilepsy syndrome	0.0073	0.0149	CbGbCtD
Loratadine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00726	0.0148	CbGbCtD
Loratadine—CYP2C9—Propofol—epilepsy syndrome	0.00709	0.0145	CbGbCtD
Loratadine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00686	0.014	CbGbCtD
Loratadine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00678	0.0139	CbGbCtD
Loratadine—ABCB1—Phenobarbital—epilepsy syndrome	0.00658	0.0134	CbGbCtD
Loratadine—ABCB1—Midazolam—epilepsy syndrome	0.00648	0.0133	CbGbCtD
Loratadine—CYP2D6—Propofol—epilepsy syndrome	0.00648	0.0133	CbGbCtD
Loratadine—CYP2C9—Diazepam—epilepsy syndrome	0.00642	0.0131	CbGbCtD
Loratadine—ABCB1—Diazepam—epilepsy syndrome	0.00623	0.0127	CbGbCtD
Loratadine—CYP3A4—Clonazepam—epilepsy syndrome	0.0062	0.0127	CbGbCtD
Loratadine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00609	0.0125	CbGbCtD
Loratadine—CYP3A4—Clobazam—epilepsy syndrome	0.00595	0.0122	CbGbCtD
Loratadine—CYP2C19—Topiramate—epilepsy syndrome	0.0055	0.0112	CbGbCtD
Loratadine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00506	0.0104	CbGbCtD
Loratadine—CYP3A4—Rufinamide—epilepsy syndrome	0.00506	0.0103	CbGbCtD
Loratadine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00493	0.0101	CbGbCtD
Loratadine—CYP3A4—Primidone—epilepsy syndrome	0.0046	0.00941	CbGbCtD
Loratadine—CYP3A4—Phenytoin—epilepsy syndrome	0.00442	0.00904	CbGbCtD
Loratadine—CYP3A4—Propofol—epilepsy syndrome	0.00412	0.00843	CbGbCtD
Loratadine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00394	0.00805	CbGbCtD
Loratadine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00394	0.00805	CbGbCtD
Loratadine—CYP3A4—Midazolam—epilepsy syndrome	0.00389	0.00794	CbGbCtD
Loratadine—CYP3A4—Diazepam—epilepsy syndrome	0.00374	0.00764	CbGbCtD
Loratadine—CYP3A4—Zonisamide—epilepsy syndrome	0.00365	0.00745	CbGbCtD
Loratadine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00294	0.00602	CbGbCtD
Loratadine—CYP3A4—Topiramate—epilepsy syndrome	0.00266	0.00543	CbGbCtD
Loratadine—Desloratadine—CYP2C19—epilepsy syndrome	0.000545	0.44	CrCbGaD
Loratadine—Desloratadine—CYP2D6—epilepsy syndrome	0.000404	0.326	CrCbGaD
Loratadine—Desloratadine—ABCB1—epilepsy syndrome	0.000288	0.233	CrCbGaD
Loratadine—Rash—Midazolam—epilepsy syndrome	8.69e-05	0.000565	CcSEcCtD
Loratadine—Dizziness—Fosphenytoin—epilepsy syndrome	8.68e-05	0.000564	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.68e-05	0.000564	CcSEcCtD
Loratadine—Dermatitis—Midazolam—epilepsy syndrome	8.68e-05	0.000564	CcSEcCtD
Loratadine—Vomiting—Levetiracetam—epilepsy syndrome	8.65e-05	0.000562	CcSEcCtD
Loratadine—Epistaxis—Topiramate—epilepsy syndrome	8.64e-05	0.000562	CcSEcCtD
Loratadine—Alopecia—Gabapentin—epilepsy syndrome	8.64e-05	0.000562	CcSEcCtD
Loratadine—Discomfort—Valproic Acid—epilepsy syndrome	8.64e-05	0.000561	CcSEcCtD
Loratadine—Headache—Midazolam—epilepsy syndrome	8.63e-05	0.000561	CcSEcCtD
Loratadine—Body temperature increased—Carbamazepine—epilepsy syndrome	8.63e-05	0.000561	CcSEcCtD
Loratadine—Abdominal pain—Carbamazepine—epilepsy syndrome	8.63e-05	0.000561	CcSEcCtD
Loratadine—Diarrhoea—Diazepam—epilepsy syndrome	8.62e-05	0.00056	CcSEcCtD
Loratadine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.62e-05	0.00056	CcSEcCtD
Loratadine—Ill-defined disorder—Pregabalin—epilepsy syndrome	8.61e-05	0.00056	CcSEcCtD
Loratadine—Rash—Levetiracetam—epilepsy syndrome	8.58e-05	0.000558	CcSEcCtD
Loratadine—Dermatitis—Levetiracetam—epilepsy syndrome	8.57e-05	0.000557	CcSEcCtD
Loratadine—Asthenia—Zonisamide—epilepsy syndrome	8.57e-05	0.000557	CcSEcCtD
Loratadine—Dry mouth—Valproic Acid—epilepsy syndrome	8.55e-05	0.000556	CcSEcCtD
Loratadine—Agitation—Pregabalin—epilepsy syndrome	8.53e-05	0.000554	CcSEcCtD
Loratadine—Headache—Levetiracetam—epilepsy syndrome	8.52e-05	0.000554	CcSEcCtD
Loratadine—Angioedema—Pregabalin—epilepsy syndrome	8.48e-05	0.000551	CcSEcCtD
Loratadine—Dizziness—Vigabatrin—epilepsy syndrome	8.47e-05	0.00055	CcSEcCtD
Loratadine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.38e-05	0.000545	CcSEcCtD
Loratadine—Malaise—Pregabalin—epilepsy syndrome	8.37e-05	0.000544	CcSEcCtD
Loratadine—Nausea—Propofol—epilepsy syndrome	8.37e-05	0.000544	CcSEcCtD
Loratadine—Tension—Gabapentin—epilepsy syndrome	8.35e-05	0.000543	CcSEcCtD
Loratadine—Vomiting—Fosphenytoin—epilepsy syndrome	8.35e-05	0.000543	CcSEcCtD
Loratadine—Diarrhoea—Felbamate—epilepsy syndrome	8.35e-05	0.000542	CcSEcCtD
Loratadine—Abdominal pain—Lamotrigine—epilepsy syndrome	8.34e-05	0.000542	CcSEcCtD
Loratadine—Body temperature increased—Lamotrigine—epilepsy syndrome	8.34e-05	0.000542	CcSEcCtD
Loratadine—Dysgeusia—Gabapentin—epilepsy syndrome	8.33e-05	0.000542	CcSEcCtD
Loratadine—Dizziness—Diazepam—epilepsy syndrome	8.33e-05	0.000542	CcSEcCtD
Loratadine—Syncope—Pregabalin—epilepsy syndrome	8.32e-05	0.000541	CcSEcCtD
Loratadine—Rash—Fosphenytoin—epilepsy syndrome	8.28e-05	0.000538	CcSEcCtD
Loratadine—Dermatitis—Fosphenytoin—epilepsy syndrome	8.27e-05	0.000538	CcSEcCtD
Loratadine—Nervousness—Gabapentin—epilepsy syndrome	8.27e-05	0.000537	CcSEcCtD
Loratadine—Asthenia—Clonazepam—epilepsy syndrome	8.26e-05	0.000537	CcSEcCtD
Loratadine—Headache—Fosphenytoin—epilepsy syndrome	8.23e-05	0.000535	CcSEcCtD
Loratadine—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.22e-05	0.000534	CcSEcCtD
Loratadine—Palpitations—Pregabalin—epilepsy syndrome	8.2e-05	0.000533	CcSEcCtD
Loratadine—Asthenia—Phenytoin—epilepsy syndrome	8.2e-05	0.000533	CcSEcCtD
Loratadine—Nausea—Midazolam—epilepsy syndrome	8.18e-05	0.000532	CcSEcCtD
Loratadine—Tachycardia—Valproic Acid—epilepsy syndrome	8.18e-05	0.000532	CcSEcCtD
Loratadine—Diarrhoea—Zonisamide—epilepsy syndrome	8.17e-05	0.000531	CcSEcCtD
Loratadine—Pharyngitis—Topiramate—epilepsy syndrome	8.16e-05	0.000531	CcSEcCtD
Loratadine—Loss of consciousness—Pregabalin—epilepsy syndrome	8.16e-05	0.00053	CcSEcCtD
Loratadine—Asthenia—Oxcarbazepine—epilepsy syndrome	8.16e-05	0.00053	CcSEcCtD
Loratadine—Vomiting—Vigabatrin—epilepsy syndrome	8.14e-05	0.000529	CcSEcCtD
Loratadine—Skin disorder—Valproic Acid—epilepsy syndrome	8.14e-05	0.000529	CcSEcCtD
Loratadine—Cough—Pregabalin—epilepsy syndrome	8.1e-05	0.000526	CcSEcCtD
Loratadine—Nausea—Levetiracetam—epilepsy syndrome	8.08e-05	0.000525	CcSEcCtD
Loratadine—Rash—Vigabatrin—epilepsy syndrome	8.07e-05	0.000525	CcSEcCtD
Loratadine—Dizziness—Felbamate—epilepsy syndrome	8.07e-05	0.000524	CcSEcCtD
Loratadine—Dermatitis—Vigabatrin—epilepsy syndrome	8.06e-05	0.000524	CcSEcCtD
Loratadine—Headache—Vigabatrin—epilepsy syndrome	8.02e-05	0.000521	CcSEcCtD
Loratadine—Hypertension—Pregabalin—epilepsy syndrome	8.01e-05	0.000521	CcSEcCtD
Loratadine—Vomiting—Diazepam—epilepsy syndrome	8.01e-05	0.000521	CcSEcCtD
Loratadine—Rash—Diazepam—epilepsy syndrome	7.95e-05	0.000516	CcSEcCtD
Loratadine—Dermatitis—Diazepam—epilepsy syndrome	7.94e-05	0.000516	CcSEcCtD
Loratadine—Chest pain—Pregabalin—epilepsy syndrome	7.9e-05	0.000514	CcSEcCtD
Loratadine—Myalgia—Pregabalin—epilepsy syndrome	7.9e-05	0.000514	CcSEcCtD
Loratadine—Ill-defined disorder—Gabapentin—epilepsy syndrome	7.9e-05	0.000513	CcSEcCtD
Loratadine—Dizziness—Zonisamide—epilepsy syndrome	7.9e-05	0.000513	CcSEcCtD
Loratadine—Headache—Diazepam—epilepsy syndrome	7.9e-05	0.000513	CcSEcCtD
Loratadine—Diarrhoea—Clonazepam—epilepsy syndrome	7.87e-05	0.000512	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.85e-05	0.00051	CcSEcCtD
Loratadine—Hypotension—Valproic Acid—epilepsy syndrome	7.83e-05	0.000509	CcSEcCtD
Loratadine—Asthenia—Carbamazepine—epilepsy syndrome	7.83e-05	0.000509	CcSEcCtD
Loratadine—Agitation—Gabapentin—epilepsy syndrome	7.82e-05	0.000508	CcSEcCtD
Loratadine—Diarrhoea—Phenytoin—epilepsy syndrome	7.82e-05	0.000508	CcSEcCtD
Loratadine—Discomfort—Pregabalin—epilepsy syndrome	7.81e-05	0.000507	CcSEcCtD
Loratadine—Nausea—Fosphenytoin—epilepsy syndrome	7.8e-05	0.000507	CcSEcCtD
Loratadine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.78e-05	0.000506	CcSEcCtD
Loratadine—Angioedema—Gabapentin—epilepsy syndrome	7.78e-05	0.000505	CcSEcCtD
Loratadine—Vomiting—Felbamate—epilepsy syndrome	7.76e-05	0.000504	CcSEcCtD
Loratadine—Dry mouth—Pregabalin—epilepsy syndrome	7.73e-05	0.000502	CcSEcCtD
Loratadine—Rash—Felbamate—epilepsy syndrome	7.69e-05	0.0005	CcSEcCtD
Loratadine—Dermatitis—Felbamate—epilepsy syndrome	7.68e-05	0.000499	CcSEcCtD
Loratadine—Malaise—Gabapentin—epilepsy syndrome	7.68e-05	0.000499	CcSEcCtD
Loratadine—Tinnitus—Topiramate—epilepsy syndrome	7.67e-05	0.000498	CcSEcCtD
Loratadine—Headache—Felbamate—epilepsy syndrome	7.64e-05	0.000497	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.63e-05	0.000496	CcSEcCtD
Loratadine—Syncope—Gabapentin—epilepsy syndrome	7.63e-05	0.000496	CcSEcCtD
Loratadine—Dizziness—Clonazepam—epilepsy syndrome	7.61e-05	0.000495	CcSEcCtD
Loratadine—Nausea—Vigabatrin—epilepsy syndrome	7.6e-05	0.000494	CcSEcCtD
Loratadine—Vomiting—Zonisamide—epilepsy syndrome	7.59e-05	0.000493	CcSEcCtD
Loratadine—Insomnia—Valproic Acid—epilepsy syndrome	7.58e-05	0.000493	CcSEcCtD
Loratadine—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.58e-05	0.000492	CcSEcCtD
Loratadine—Asthenia—Lamotrigine—epilepsy syndrome	7.57e-05	0.000492	CcSEcCtD
Loratadine—Dizziness—Phenytoin—epilepsy syndrome	7.56e-05	0.000491	CcSEcCtD
Loratadine—Rash—Zonisamide—epilepsy syndrome	7.53e-05	0.000489	CcSEcCtD
Loratadine—Paraesthesia—Valproic Acid—epilepsy syndrome	7.52e-05	0.000489	CcSEcCtD
Loratadine—Palpitations—Gabapentin—epilepsy syndrome	7.52e-05	0.000489	CcSEcCtD
Loratadine—Dermatitis—Zonisamide—epilepsy syndrome	7.52e-05	0.000489	CcSEcCtD
Loratadine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.52e-05	0.000489	CcSEcCtD
Loratadine—Nausea—Diazepam—epilepsy syndrome	7.49e-05	0.000487	CcSEcCtD
Loratadine—Loss of consciousness—Gabapentin—epilepsy syndrome	7.48e-05	0.000486	CcSEcCtD
Loratadine—Headache—Zonisamide—epilepsy syndrome	7.48e-05	0.000486	CcSEcCtD
Loratadine—Diarrhoea—Carbamazepine—epilepsy syndrome	7.47e-05	0.000485	CcSEcCtD
Loratadine—Shock—Pregabalin—epilepsy syndrome	7.45e-05	0.000484	CcSEcCtD
Loratadine—Somnolence—Valproic Acid—epilepsy syndrome	7.45e-05	0.000484	CcSEcCtD
Loratadine—Immune system disorder—Topiramate—epilepsy syndrome	7.43e-05	0.000483	CcSEcCtD
Loratadine—Nervous system disorder—Pregabalin—epilepsy syndrome	7.43e-05	0.000483	CcSEcCtD
Loratadine—Cough—Gabapentin—epilepsy syndrome	7.43e-05	0.000483	CcSEcCtD
Loratadine—Tachycardia—Pregabalin—epilepsy syndrome	7.39e-05	0.000481	CcSEcCtD
Loratadine—Dyspepsia—Valproic Acid—epilepsy syndrome	7.38e-05	0.000479	CcSEcCtD
Loratadine—Skin disorder—Pregabalin—epilepsy syndrome	7.36e-05	0.000478	CcSEcCtD
Loratadine—Hypertension—Gabapentin—epilepsy syndrome	7.35e-05	0.000478	CcSEcCtD
Loratadine—Vomiting—Clonazepam—epilepsy syndrome	7.32e-05	0.000476	CcSEcCtD
Loratadine—Alopecia—Topiramate—epilepsy syndrome	7.27e-05	0.000472	CcSEcCtD
Loratadine—Vomiting—Phenytoin—epilepsy syndrome	7.27e-05	0.000472	CcSEcCtD
Loratadine—Rash—Clonazepam—epilepsy syndrome	7.26e-05	0.000472	CcSEcCtD
Loratadine—Dermatitis—Clonazepam—epilepsy syndrome	7.25e-05	0.000471	CcSEcCtD
Loratadine—Chest pain—Gabapentin—epilepsy syndrome	7.25e-05	0.000471	CcSEcCtD
Loratadine—Myalgia—Gabapentin—epilepsy syndrome	7.25e-05	0.000471	CcSEcCtD
Loratadine—Nausea—Felbamate—epilepsy syndrome	7.25e-05	0.000471	CcSEcCtD
Loratadine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.23e-05	0.00047	CcSEcCtD
Loratadine—Vomiting—Oxcarbazepine—epilepsy syndrome	7.23e-05	0.00047	CcSEcCtD
Loratadine—Fatigue—Valproic Acid—epilepsy syndrome	7.22e-05	0.00047	CcSEcCtD
Loratadine—Dizziness—Carbamazepine—epilepsy syndrome	7.21e-05	0.000469	CcSEcCtD
Loratadine—Diarrhoea—Lamotrigine—epilepsy syndrome	7.21e-05	0.000469	CcSEcCtD
Loratadine—Headache—Clonazepam—epilepsy syndrome	7.21e-05	0.000469	CcSEcCtD
Loratadine—Rash—Phenytoin—epilepsy syndrome	7.21e-05	0.000468	CcSEcCtD
Loratadine—Dermatitis—Phenytoin—epilepsy syndrome	7.2e-05	0.000468	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.2e-05	0.000468	CcSEcCtD
Loratadine—Rash—Oxcarbazepine—epilepsy syndrome	7.17e-05	0.000466	CcSEcCtD
Loratadine—Pain—Valproic Acid—epilepsy syndrome	7.17e-05	0.000466	CcSEcCtD
Loratadine—Constipation—Valproic Acid—epilepsy syndrome	7.17e-05	0.000466	CcSEcCtD
Loratadine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.16e-05	0.000466	CcSEcCtD
Loratadine—Headache—Phenytoin—epilepsy syndrome	7.16e-05	0.000465	CcSEcCtD
Loratadine—Discomfort—Gabapentin—epilepsy syndrome	7.16e-05	0.000465	CcSEcCtD
Loratadine—Headache—Oxcarbazepine—epilepsy syndrome	7.12e-05	0.000463	CcSEcCtD
Loratadine—Nausea—Zonisamide—epilepsy syndrome	7.09e-05	0.000461	CcSEcCtD
Loratadine—Dry mouth—Gabapentin—epilepsy syndrome	7.09e-05	0.000461	CcSEcCtD
Loratadine—Hypotension—Pregabalin—epilepsy syndrome	7.08e-05	0.00046	CcSEcCtD
Loratadine—Tension—Topiramate—epilepsy syndrome	7.03e-05	0.000457	CcSEcCtD
Loratadine—Dysgeusia—Topiramate—epilepsy syndrome	7.01e-05	0.000456	CcSEcCtD
Loratadine—Dizziness—Lamotrigine—epilepsy syndrome	6.97e-05	0.000453	CcSEcCtD
Loratadine—Nervousness—Topiramate—epilepsy syndrome	6.95e-05	0.000452	CcSEcCtD
Loratadine—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.95e-05	0.000451	CcSEcCtD
Loratadine—Vomiting—Carbamazepine—epilepsy syndrome	6.94e-05	0.000451	CcSEcCtD
Loratadine—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.9e-05	0.000449	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.9e-05	0.000449	CcSEcCtD
Loratadine—Rash—Carbamazepine—epilepsy syndrome	6.88e-05	0.000447	CcSEcCtD
Loratadine—Dermatitis—Carbamazepine—epilepsy syndrome	6.87e-05	0.000447	CcSEcCtD
Loratadine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.85e-05	0.000445	CcSEcCtD
Loratadine—Insomnia—Pregabalin—epilepsy syndrome	6.85e-05	0.000445	CcSEcCtD
Loratadine—Nausea—Clonazepam—epilepsy syndrome	6.84e-05	0.000444	CcSEcCtD
Loratadine—Headache—Carbamazepine—epilepsy syndrome	6.84e-05	0.000444	CcSEcCtD
Loratadine—Shock—Gabapentin—epilepsy syndrome	6.83e-05	0.000444	CcSEcCtD
Loratadine—Nervous system disorder—Gabapentin—epilepsy syndrome	6.81e-05	0.000443	CcSEcCtD
Loratadine—Paraesthesia—Pregabalin—epilepsy syndrome	6.8e-05	0.000442	CcSEcCtD
Loratadine—Nausea—Phenytoin—epilepsy syndrome	6.79e-05	0.000441	CcSEcCtD
Loratadine—Tachycardia—Gabapentin—epilepsy syndrome	6.78e-05	0.000441	CcSEcCtD
Loratadine—Nausea—Oxcarbazepine—epilepsy syndrome	6.75e-05	0.000439	CcSEcCtD
Loratadine—Skin disorder—Gabapentin—epilepsy syndrome	6.75e-05	0.000439	CcSEcCtD
Loratadine—Somnolence—Pregabalin—epilepsy syndrome	6.73e-05	0.000438	CcSEcCtD
Loratadine—Vomiting—Lamotrigine—epilepsy syndrome	6.7e-05	0.000436	CcSEcCtD
Loratadine—Rash—Lamotrigine—epilepsy syndrome	6.65e-05	0.000432	CcSEcCtD
Loratadine—Ill-defined disorder—Topiramate—epilepsy syndrome	6.64e-05	0.000432	CcSEcCtD
Loratadine—Dermatitis—Lamotrigine—epilepsy syndrome	6.64e-05	0.000432	CcSEcCtD
Loratadine—Body temperature increased—Valproic Acid—epilepsy syndrome	6.62e-05	0.000431	CcSEcCtD
Loratadine—Abdominal pain—Valproic Acid—epilepsy syndrome	6.62e-05	0.000431	CcSEcCtD
Loratadine—Headache—Lamotrigine—epilepsy syndrome	6.61e-05	0.000429	CcSEcCtD
Loratadine—Agitation—Topiramate—epilepsy syndrome	6.58e-05	0.000428	CcSEcCtD
Loratadine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.54e-05	0.000425	CcSEcCtD
Loratadine—Fatigue—Pregabalin—epilepsy syndrome	6.53e-05	0.000424	CcSEcCtD
Loratadine—Hypotension—Gabapentin—epilepsy syndrome	6.49e-05	0.000422	CcSEcCtD
Loratadine—Nausea—Carbamazepine—epilepsy syndrome	6.48e-05	0.000421	CcSEcCtD
Loratadine—Pain—Pregabalin—epilepsy syndrome	6.48e-05	0.000421	CcSEcCtD
Loratadine—Constipation—Pregabalin—epilepsy syndrome	6.48e-05	0.000421	CcSEcCtD
Loratadine—Malaise—Topiramate—epilepsy syndrome	6.46e-05	0.00042	CcSEcCtD
Loratadine—Syncope—Topiramate—epilepsy syndrome	6.42e-05	0.000417	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.33e-05	0.000411	CcSEcCtD
Loratadine—Palpitations—Topiramate—epilepsy syndrome	6.33e-05	0.000411	CcSEcCtD
Loratadine—Loss of consciousness—Topiramate—epilepsy syndrome	6.29e-05	0.000409	CcSEcCtD
Loratadine—Insomnia—Gabapentin—epilepsy syndrome	6.28e-05	0.000408	CcSEcCtD
Loratadine—Nausea—Lamotrigine—epilepsy syndrome	6.26e-05	0.000407	CcSEcCtD
Loratadine—Cough—Topiramate—epilepsy syndrome	6.25e-05	0.000406	CcSEcCtD
Loratadine—Feeling abnormal—Pregabalin—epilepsy syndrome	6.24e-05	0.000406	CcSEcCtD
Loratadine—Paraesthesia—Gabapentin—epilepsy syndrome	6.24e-05	0.000405	CcSEcCtD
Loratadine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.19e-05	0.000403	CcSEcCtD
Loratadine—Hypertension—Topiramate—epilepsy syndrome	6.18e-05	0.000402	CcSEcCtD
Loratadine—Somnolence—Gabapentin—epilepsy syndrome	6.18e-05	0.000401	CcSEcCtD
Loratadine—Dyspepsia—Gabapentin—epilepsy syndrome	6.11e-05	0.000397	CcSEcCtD
Loratadine—Myalgia—Topiramate—epilepsy syndrome	6.1e-05	0.000396	CcSEcCtD
Loratadine—Chest pain—Topiramate—epilepsy syndrome	6.1e-05	0.000396	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.05e-05	0.000394	CcSEcCtD
Loratadine—Discomfort—Topiramate—epilepsy syndrome	6.02e-05	0.000391	CcSEcCtD
Loratadine—Asthenia—Valproic Acid—epilepsy syndrome	6.01e-05	0.000391	CcSEcCtD
Loratadine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6e-05	0.00039	CcSEcCtD
Loratadine—Fatigue—Gabapentin—epilepsy syndrome	5.99e-05	0.000389	CcSEcCtD
Loratadine—Abdominal pain—Pregabalin—epilepsy syndrome	5.99e-05	0.000389	CcSEcCtD
Loratadine—Body temperature increased—Pregabalin—epilepsy syndrome	5.99e-05	0.000389	CcSEcCtD
Loratadine—Dry mouth—Topiramate—epilepsy syndrome	5.96e-05	0.000388	CcSEcCtD
Loratadine—Pain—Gabapentin—epilepsy syndrome	5.94e-05	0.000386	CcSEcCtD
Loratadine—Constipation—Gabapentin—epilepsy syndrome	5.94e-05	0.000386	CcSEcCtD
Loratadine—Shock—Topiramate—epilepsy syndrome	5.75e-05	0.000374	CcSEcCtD
Loratadine—Diarrhoea—Valproic Acid—epilepsy syndrome	5.73e-05	0.000373	CcSEcCtD
Loratadine—Nervous system disorder—Topiramate—epilepsy syndrome	5.73e-05	0.000372	CcSEcCtD
Loratadine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.72e-05	0.000372	CcSEcCtD
Loratadine—Tachycardia—Topiramate—epilepsy syndrome	5.7e-05	0.000371	CcSEcCtD
Loratadine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.68e-05	0.000369	CcSEcCtD
Loratadine—Skin disorder—Topiramate—epilepsy syndrome	5.68e-05	0.000369	CcSEcCtD
Loratadine—Dizziness—Valproic Acid—epilepsy syndrome	5.54e-05	0.00036	CcSEcCtD
Loratadine—Abdominal pain—Gabapentin—epilepsy syndrome	5.49e-05	0.000357	CcSEcCtD
Loratadine—Body temperature increased—Gabapentin—epilepsy syndrome	5.49e-05	0.000357	CcSEcCtD
Loratadine—Hypotension—Topiramate—epilepsy syndrome	5.46e-05	0.000355	CcSEcCtD
Loratadine—Asthenia—Pregabalin—epilepsy syndrome	5.44e-05	0.000353	CcSEcCtD
Loratadine—Vomiting—Valproic Acid—epilepsy syndrome	5.33e-05	0.000346	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.32e-05	0.000346	CcSEcCtD
Loratadine—Insomnia—Topiramate—epilepsy syndrome	5.29e-05	0.000344	CcSEcCtD
Loratadine—Rash—Valproic Acid—epilepsy syndrome	5.28e-05	0.000343	CcSEcCtD
Loratadine—Dermatitis—Valproic Acid—epilepsy syndrome	5.28e-05	0.000343	CcSEcCtD
Loratadine—Headache—Valproic Acid—epilepsy syndrome	5.25e-05	0.000341	CcSEcCtD
Loratadine—Paraesthesia—Topiramate—epilepsy syndrome	5.25e-05	0.000341	CcSEcCtD
Loratadine—Somnolence—Topiramate—epilepsy syndrome	5.2e-05	0.000338	CcSEcCtD
Loratadine—Diarrhoea—Pregabalin—epilepsy syndrome	5.18e-05	0.000337	CcSEcCtD
Loratadine—Dyspepsia—Topiramate—epilepsy syndrome	5.14e-05	0.000334	CcSEcCtD
Loratadine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.05e-05	0.000328	CcSEcCtD
Loratadine—Fatigue—Topiramate—epilepsy syndrome	5.04e-05	0.000327	CcSEcCtD
Loratadine—Dizziness—Pregabalin—epilepsy syndrome	5.01e-05	0.000326	CcSEcCtD
Loratadine—Constipation—Topiramate—epilepsy syndrome	5e-05	0.000325	CcSEcCtD
Loratadine—Pain—Topiramate—epilepsy syndrome	5e-05	0.000325	CcSEcCtD
Loratadine—Asthenia—Gabapentin—epilepsy syndrome	4.98e-05	0.000324	CcSEcCtD
Loratadine—Nausea—Valproic Acid—epilepsy syndrome	4.98e-05	0.000323	CcSEcCtD
Loratadine—Vomiting—Pregabalin—epilepsy syndrome	4.82e-05	0.000313	CcSEcCtD
Loratadine—Feeling abnormal—Topiramate—epilepsy syndrome	4.82e-05	0.000313	CcSEcCtD
Loratadine—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.78e-05	0.000311	CcSEcCtD
Loratadine—Rash—Pregabalin—epilepsy syndrome	4.78e-05	0.00031	CcSEcCtD
Loratadine—Dermatitis—Pregabalin—epilepsy syndrome	4.77e-05	0.00031	CcSEcCtD
Loratadine—Diarrhoea—Gabapentin—epilepsy syndrome	4.75e-05	0.000309	CcSEcCtD
Loratadine—Headache—Pregabalin—epilepsy syndrome	4.75e-05	0.000308	CcSEcCtD
Loratadine—Abdominal pain—Topiramate—epilepsy syndrome	4.62e-05	0.0003	CcSEcCtD
Loratadine—Body temperature increased—Topiramate—epilepsy syndrome	4.62e-05	0.0003	CcSEcCtD
Loratadine—Dizziness—Gabapentin—epilepsy syndrome	4.59e-05	0.000299	CcSEcCtD
Loratadine—Nausea—Pregabalin—epilepsy syndrome	4.5e-05	0.000292	CcSEcCtD
Loratadine—Vomiting—Gabapentin—epilepsy syndrome	4.42e-05	0.000287	CcSEcCtD
Loratadine—Rash—Gabapentin—epilepsy syndrome	4.38e-05	0.000285	CcSEcCtD
Loratadine—Dermatitis—Gabapentin—epilepsy syndrome	4.38e-05	0.000284	CcSEcCtD
Loratadine—Headache—Gabapentin—epilepsy syndrome	4.35e-05	0.000283	CcSEcCtD
Loratadine—Asthenia—Topiramate—epilepsy syndrome	4.19e-05	0.000273	CcSEcCtD
Loratadine—Nausea—Gabapentin—epilepsy syndrome	4.13e-05	0.000268	CcSEcCtD
Loratadine—Diarrhoea—Topiramate—epilepsy syndrome	4e-05	0.00026	CcSEcCtD
Loratadine—Dizziness—Topiramate—epilepsy syndrome	3.86e-05	0.000251	CcSEcCtD
Loratadine—Vomiting—Topiramate—epilepsy syndrome	3.72e-05	0.000242	CcSEcCtD
Loratadine—Rash—Topiramate—epilepsy syndrome	3.68e-05	0.000239	CcSEcCtD
Loratadine—Dermatitis—Topiramate—epilepsy syndrome	3.68e-05	0.000239	CcSEcCtD
Loratadine—Headache—Topiramate—epilepsy syndrome	3.66e-05	0.000238	CcSEcCtD
Loratadine—Nausea—Topiramate—epilepsy syndrome	3.47e-05	0.000226	CcSEcCtD
Loratadine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	7.35e-06	0.000134	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	7.34e-06	0.000134	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	7.31e-06	0.000133	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	7.29e-06	0.000133	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	7.22e-06	0.000131	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	7.22e-06	0.000131	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	7.21e-06	0.000131	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	7.2e-06	0.000131	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	7.16e-06	0.00013	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	7.15e-06	0.00013	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AQP1—epilepsy syndrome	7.12e-06	0.00013	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.11e-06	0.00013	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.07e-06	0.000129	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.07e-06	0.000129	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.07e-06	0.000129	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.07e-06	0.000129	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.07e-06	0.000129	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.05e-06	0.000128	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.95e-06	0.000127	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	6.94e-06	0.000126	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.84e-06	0.000125	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	6.8e-06	0.000124	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.79e-06	0.000124	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.75e-06	0.000123	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.72e-06	0.000122	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.69e-06	0.000122	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	6.62e-06	0.000121	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	6.62e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.58e-06	0.00012	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.55e-06	0.000119	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.49e-06	0.000118	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.46e-06	0.000118	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.46e-06	0.000118	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.46e-06	0.000118	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	6.45e-06	0.000117	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	6.44e-06	0.000117	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	6.44e-06	0.000117	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	6.39e-06	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	6.39e-06	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	6.39e-06	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	6.39e-06	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	6.39e-06	0.000116	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	6.35e-06	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	6.3e-06	0.000115	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CHRM3—epilepsy syndrome	6.29e-06	0.000114	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	6.29e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.24e-06	0.000114	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.22e-06	0.000113	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	6.17e-06	0.000112	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.01e-06	0.000109	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.01e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6e-06	0.000109	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.96e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	5.94e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	5.94e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.92e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.92e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	5.88e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.88e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.87e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.87e-06	0.000107	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	5.85e-06	0.000107	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	5.78e-06	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SST—epilepsy syndrome	5.78e-06	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	5.78e-06	0.000105	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	5.73e-06	0.000104	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	5.73e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	5.7e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.66e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	5.65e-06	0.000103	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.65e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	5.63e-06	0.000103	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.5e-06	0.0001	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.47e-06	9.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	5.43e-06	9.89e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	5.43e-06	9.89e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	5.43e-06	9.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	5.41e-06	9.85e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	5.39e-06	9.81e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.36e-06	9.76e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.36e-06	9.76e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.36e-06	9.76e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	5.33e-06	9.71e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	5.33e-06	9.71e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	5.31e-06	9.68e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	5.25e-06	9.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	5.2e-06	9.48e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.16e-06	9.39e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	5.14e-06	9.36e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.12e-06	9.33e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.11e-06	9.31e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.11e-06	9.31e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	5.08e-06	9.26e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	5.05e-06	9.2e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.05e-06	9.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5e-06	9.11e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.99e-06	9.09e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.96e-06	9.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	4.96e-06	9.03e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	4.93e-06	8.97e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.9e-06	8.92e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.89e-06	8.91e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.87e-06	8.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	4.84e-06	8.82e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.83e-06	8.79e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	4.82e-06	8.78e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.8e-06	8.75e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.79e-06	8.72e-05	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.73e-06	8.61e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.72e-06	8.59e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.71e-06	8.57e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.68e-06	8.52e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.66e-06	8.5e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	4.65e-06	8.47e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.64e-06	8.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.6e-06	8.38e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.6e-06	8.38e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	4.6e-06	8.37e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.59e-06	8.36e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TH—epilepsy syndrome	4.58e-06	8.34e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	4.58e-06	8.34e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	4.53e-06	8.26e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	4.52e-06	8.24e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.51e-06	8.22e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.48e-06	8.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.41e-06	8.03e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	4.38e-06	7.98e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4.37e-06	7.96e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	4.35e-06	7.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.28e-06	7.8e-05	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.27e-06	7.78e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.26e-06	7.76e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.25e-06	7.73e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.2e-06	7.64e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.18e-06	7.62e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	4.15e-06	7.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	4.14e-06	7.54e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	4.1e-06	7.48e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TH—epilepsy syndrome	4.09e-06	7.45e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.05e-06	7.38e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	4.03e-06	7.33e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.03e-06	7.33e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	4.02e-06	7.32e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	4.01e-06	7.31e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.01e-06	7.3e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	4.01e-06	7.29e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	4e-06	7.29e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TH—epilepsy syndrome	3.99e-06	7.27e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.98e-06	7.25e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.97e-06	7.22e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.87e-06	7.05e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.87e-06	7.05e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.87e-06	7.05e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	3.83e-06	6.97e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.82e-06	6.96e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.82e-06	6.95e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.78e-06	6.89e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.78e-06	6.88e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.77e-06	6.87e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TH—epilepsy syndrome	3.76e-06	6.85e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.74e-06	6.82e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TH—epilepsy syndrome	3.73e-06	6.79e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	3.72e-06	6.78e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.67e-06	6.69e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.67e-06	6.68e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	3.64e-06	6.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	3.46e-06	6.3e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	3.46e-06	6.3e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.41e-06	6.22e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.41e-06	6.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	3.39e-06	6.17e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.37e-06	6.13e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.33e-06	6.07e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	3.32e-06	6.04e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAT—epilepsy syndrome	3.29e-06	5.99e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.28e-06	5.97e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	3.19e-06	5.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	3.18e-06	5.79e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.16e-06	5.75e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.14e-06	5.72e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.11e-06	5.67e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.1e-06	5.64e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.08e-06	5.6e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.07e-06	5.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.06e-06	5.57e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.05e-06	5.55e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.01e-06	5.49e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.99e-06	5.45e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.99e-06	5.44e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.97e-06	5.41e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.93e-06	5.34e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	2.91e-06	5.3e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	2.85e-06	5.19e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.8e-06	5.1e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.78e-06	5.06e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.76e-06	5.03e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.67e-06	4.86e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.63e-06	4.78e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.62e-06	4.77e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.62e-06	4.76e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.61e-06	4.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	2.57e-06	4.69e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.55e-06	4.65e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.52e-06	4.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.5e-06	4.54e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.47e-06	4.5e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.46e-06	4.48e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.46e-06	4.47e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.44e-06	4.44e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.41e-06	4.38e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	2.39e-06	4.35e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.39e-06	4.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	2.34e-06	4.27e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.3e-06	4.18e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.25e-06	4.09e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—POMC—epilepsy syndrome	2.19e-06	4e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.17e-06	3.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.15e-06	3.92e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.09e-06	3.81e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.07e-06	3.77e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.05e-06	3.74e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.05e-06	3.73e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.05e-06	3.73e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.04e-06	3.71e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.03e-06	3.69e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.01e-06	3.66e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—epilepsy syndrome	2e-06	3.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	1.97e-06	3.6e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.97e-06	3.59e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.89e-06	3.43e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	1.88e-06	3.42e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.87e-06	3.4e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.83e-06	3.34e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	1.83e-06	3.33e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.79e-06	3.27e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.75e-06	3.19e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.65e-06	3e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.64e-06	2.98e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.61e-06	2.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.57e-06	2.87e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.35e-06	2.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.23e-06	2.24e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.17e-06	2.12e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	1.96e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.01e-06	1.84e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	9.01e-07	1.64e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.8e-07	1.6e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	8.29e-07	1.51e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	8.22e-07	1.5e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.42e-07	9.87e-06	CbGpPWpGaD
